Salute e Benessere

Implantica publishes Interim Report January - June 2024 (Q2)

Significant events after the end of the period Significant events after the end of the period Financial summary second quarter 2024 First six months Telephone conference Implantica will hold a teleconference on21 August 2024at 15:00 (CEST) withPeter Forsell(CEO), Andreas Öhrnberg (CFO), andNicole Pehrsson(Chief Corporate Affairs Officer). Please see the dial-in details below to join the conference: Webcast If you wish to participate via webcast, please use...
PR Newswire
21/08/2024

Interim report- SciBase

The second quarter in figures The second quarter in figures January - June in figures Important events during the quarter Important events after the end of the period Financial overview This information is information that SciBase Holding AB is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out below, at 08.00 CET onAugust 21, 2024. This interim...
PR Newswire
21/08/2024

Strong Cresemba® (isavuconazole) sales performance in Asia Pacific and China…

Allschwil, Switzerland, August 21, 2024 Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a commercial-stage biopharmaceutical company committed to meeting the needs of patients with severe bacterial and fungal infections, announced today that the continued strong sales performance of the antifungal Cresemba ®(isavuconazole) by its license partner Pfizer Inc. in the Asia Pacific region and China exceeded the sales threshold triggering a USD 1.25 million milestone payment. David Veitch,...
Nasdaq GlobeNewswire
21/08/2024

BerGenBio Second Quarter Results 2024: Solid clinical and financial progress

Martin Olin, Chief Executive Officer of BerGenBio stated: Martin Olin, Chief Executive Officer of BerGenBio stated: "The BGBC016 clinical trial continued to progress well during the quarter. An independent review of the final cohort in the Ph1b part showed acceptable safety allowing initiation of the 2 nddose in the Ph2a part, and we completed the activation of the Ph2a sites. We now look forward to sharing preliminary efficacy data from the Ph2a portion of the study as they mature...
PR Newswire
21/08/2024

Ultimovacs ASA Reports Second Quarter 2024 Financial Results and Provides…

Oslo, August 21, 2024:Ultimovacs ASA ("Ultimovacs") (OSE ULTI), a clinical-stage biotechnology company developing novel immunotherapies against cancer, announces its second quarter 2024 results today. Conference call and webcast scheduled for August 21, 2024, at 14:00 (CET). Link to webcast here .Second Quarter 2024 Business UpdateFollowing the negative INITIUM result in March 2024, Ultimovacs implemented cash preservation initiatives during the second quarter of 2024...
Nasdaq GlobeNewswire
21/08/2024

Galapagos receives transparency notification from FMR LLC

Mechelen, Belgium; 20 August 2024, 22:01 CET; regulated information – Galapagos NV (Euronext & NASDAQ: GLPG) received a transparency notification from FMR LLC. Pursuant to Belgian transparency legislation 1, Galapagos received a transparency notification on 16 August 2024 from FMR LLC, who notified that it holds 3,696,750 of Galapagos' voting rights, consisting of 3,693,550 ordinary shares and 3,200 equivalent financial instruments. FMR LLC controls investment funds Fidelity Management...
Nasdaq GlobeNewswire
20/08/2024

Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives…

Bagsværd, Denmark, 20 August 2024— This company announcement discloses the data of the transaction(s) made in Novo Nordisk shares by the company's board members, executives and their associated persons in accordance with Article 19 of Regulation No. 596/2014 on market abuse.The company's board members, executives and their associated persons have reported the transactions to Novo Nordisk and have given Novo Nordisk power of attorney on their behalf to publish trading in Novo Nordisk...
Nasdaq GlobeNewswire
20/08/2024

KFSHRC Showcases Medical Education Innovations at AMEE 2024 Switzerland

RIYADH, Saudi Arabia, Aug.20, 2024(GLOBE NEWSWIRE) -- King Faisal Specialist Hospital & Research Centre (KFSHRC) is further expanding its global footprint by participating in the 2024 International Association for Medical Education in Europe (AMEE) Conference for the second consecutive year. Taking place from August 26 to 28 in Basel, Switzerland, this event brings together global leaders in medical education and healthcare. This year, KFSHRC's focus is on refining clinical...
Nasdaq GlobeNewswire
20/08/2024

Surgical Sponges Market worth $1.19 billion in 2029 driven by Technological…

Browse in-depth TOC on "Surgical Sponges Market" Browse in-depth TOC on "Surgical Sponges Market" 328 - Tables 44 - Figures 286 - Pages Johnson & Johnson Services, Inc.: Market Leader in Surgical Sponges Johnson & Johnson Services, Inc. (US) is a dominant player in the surgical sponges market, holding the largest market share in 2023. The company manufactures and distributes a wide range of healthcare products acrossNorth America,Europe, theMiddle East...
PR Newswire
20/08/2024

Heart Attack Diagnostics Market to Reach $21.1 Billion, Globally, by 2033 at…

Request Sample of the Report on Heart Attack Diagnostics Market Forecast 2033 - https://www.alliedmarketresearch.com/request-sample/A12689 Request Sample of the Report on Heart Attack Diagnostics Market Forecast 2033 -https://www.alliedmarketresearch.com/request-sample/A12689 Prime determinants of growth The heart attack diagnostics market is experiencing significant growth driven by several key factors such as advancements in medical imaging technologies have revolutionized...
PR Newswire
20/08/2024

Orion Corporation: Managers' transactions – Liisa Hurme

ORION CORPORATIONMANAGERS' TRANSACTIONS20 AUGUST 2024 at 16.15 EEST Orion Corporation: Managers' transactions – Liisa Hurme Orion Corporation has received the following disclosure under Market Abuse Regulation (EU) No 596/2014, regarding transactions with shares and linked securities in Orion Corporation made by managers and their closely associated persons.Orion Oyj - Managers' Transactions ____________________________________________ Person subject to the notification...
Nasdaq GlobeNewswire
20/08/2024

Carilion Clinic further expands quality cardiac care access with latest Philips…

Integrated Philips cardiovascular solutions enhance the patient & staff experience with reduced X-ray dose & procedure time for more time with patients and to help improve outcomes New facility will have 11 specialized Philips interventional suites, allowing physicians to treat patients with complex cardiovascular conditions closer to home Amsterdam, The Netherlands and Roanoke, US – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and...
Nasdaq GlobeNewswire
20/08/2024

iTeos Therapeutics Announces Late-Breaking Oral Presentation of Phase 2 GALAXIES…

Late Breaking Oral Presentation Details Title : Interim Analysis of GALAXIES Lung-201: Phase 2, Randomized, Open-label Platform Study of Belrestotug Plus Dostarlimab in Patients (pts) With Previously Untreated Locally Advanced/Metastatic (LA/M) PD-L1 High (TPS >/=50%) Non-Small Cell Lung Cancer (NSCLC)Abstract Number : LBA52Session Title : Proffered Paper Session: NSCLC MetastaticDate / Time : September 14, 2024 at 8:30 am CEST / 2:30 am ETThe ESMO website indicates that all...
Nasdaq GlobeNewswire
20/08/2024

Roche responds to WHO's declaration of a global health emergency due to the…

Roche is committed to supporting all those working to overcome the mpox outbreak by providing access to high-quality Polymerase Chain Reaction (PCR) testingRoche confirms that its cobas MPXV test, as well as the LightMix® research use only kits, detect the latest mpox virus variants It is actively working to enhance laboratory testing capacity for mpox worldwideBasel, 20 August 2024 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that it is supporting the international...
Nasdaq GlobeNewswire
20/08/2024

Infectious Disease Expert Kelly Warfield Named Sabin's New R&D President

caption: Sabin Vaccine Institute Research & Development President Kelly Warfield WASHINGTON, Aug.20, 2024(GLOBE NEWSWIRE) -- Virologist and vaccine development leader Kelly Warfield has joined the Sabin Vaccine Institute as its Research & Development President to drive Sabin's current candidate vaccines toward licensure and expand its pipeline.A member of Sabin's executive team, Warfield will manage the R&D program and team, collaborating with peers, cross-functional...
Nasdaq GlobeNewswire
20/08/2024

MAHE signs MoU with SKAN and Happiest Health for academics, research and…

Mr. Ashok Soota, Chairman & Managing Trustee of SKAN, said, "We are delighted that Manipal Academy of Higher Education (MAHE) has agreed to sign an agreement covering R&D and academic collaboration with SKAN and also an agreement to provide consultancy to Happiest Health, for various healthcare practices. MAHE is a powerhouse with vast years of experience in academics, research, and multiple healthcare practices. We look forward to advancing the frontiers of science through…
PR Newswire
20/08/2024

Extracorporeal Membrane Oxygenation Machine (ECMO) Market to Reach $793.7…

Request Sample of the Report on Extracorporeal Membrane Oxygenation Machine (ECMO) Market Forecast 2033 - https://www.alliedmarketresearch.com/request-sample/A284556 Request Sample of the Report on Extracorporeal Membrane Oxygenation Machine (ECMO) Market Forecast 2033 -https://www.alliedmarketresearch.com/request-sample/A284556 Prime determinants of growth The global extracorporeal membrane oxygenation (ECMO) machine market is experiencing growth due to several factors such...
PR Newswire
20/08/2024

Controlled Clinical Trial Results for FDA-Approved Tinnitus Treatment Device…

The published paper is available at: https://www.nature.com/articles/s41467-024-50473-z The published paper is available at:https://www.nature.com/articles/s41467-024-50473-z Lenire is a bimodal neuromodulation device which has been shown to provide relief from tinnitus that can sustain for at least 12-months after treatment in large-scale clinical trials. [2],[3]Lenire's bimodal neuromodulation pairs mild electrical pulses to the tongue through an intra-oral component called the...
PR Newswire
20/08/2024

Step Machines Market to Reach $1.8 Billion, Globally, by 2033 at 3.2% CAGR…

Download Sample Pages of Research Overview: https://www.alliedmarketresearch.com/request-sample/4281 Download Sample Pages of Research Overview: https://www.alliedmarketresearch.com/request-sample/4281 Prime determinants of growth The step machines market is mostly driven by rise in health consciousness and the popularity of at-home exercise. In addition, demand for step machines is driven by growing awareness of physical fitness and wellness among as well as the ease of at-home...
PR Newswire
20/08/2024

Adcendo ApS and Multitude Therapeutics Inc. Announce Global Development and…

TF is a clinically validated ADC target that is highly expressed in indications such as non-small cell lung cancer, colorectal cancer, cervical cancer, oesophageal cancer, head and neck cancer, bladder cancer and certain gastrointestinal cancers, but its expression is limited in normal tissues. TF is a clinically validated ADC target that is highly expressed in indications such as non-small cell lung cancer, colorectal cancer, cervical cancer, oesophageal cancer, head and neck cancer, bladder...
PR Newswire
20/08/2024

Implantica announces RefluxStop™ pivotal 4-year study results published in the…

At 4-year follow-up, patients experienced 90% improvement in GERD Health-Related Quality of Life (GERD-HRQL questionnaire) score, with no patients requiring daily medical therapy for acid reflux. 46/47 patients had no swallowing problems (dysphagia) at follow-up compared to 11 cases of mixed severity of dysphagia before surgery, which is one of the most common complications with standard of care procedures usually reaching about 30% at 5-year follow-up. No patient was dissatisfied because of…
PR Newswire
20/08/2024

New Electrolux Group study shows short wash and low temperature key to reducing…

Through extensive laboratory testing, different washing methods were tested on various fabrics, selected to represent common clothing types including denim jeans and cotton T-shirts. Color degradation was regularly monitored and over 600 panelists determined the point at which clothes would be disposed of. Through extensive laboratory testing, different washing methods were tested on various fabrics, selected to represent common clothing types including denim jeans and cotton T-shirts...
PR Newswire
20/08/2024

Bone Index Announces Successful Financing Round and Strategic Partnership with…

About Lynx Financial About Lynx Financial Lynx Financial is a boutique investment and investment banking firm that specializes in Life Sciences and Medical Technology sectors. With a global outreach and on-the-ground presence, Lynx Financial fully leverages its expertise in deal structuring and investments to help emerging innovative companies from around the world gain access to funding and strategic resources inAsia Pacificregions. For more information: Bone Index:Janne...
PR Newswire
20/08/2024

BerGenBio Collaborates with Tempus to Potentially Accelerate Development in…

Upon conclusion of the BGBC016 study, the parties intend to present insights derived from the resulting data to appropriate regulatory agencies as a next step in the further development of bemcentinib. Upon conclusion of the BGBC016 study, the parties intend to present insights derived from the resulting data to appropriate regulatory agencies as a next step in the further development of bemcentinib. Martin Olin, CEO of BerGenBio, expressed enthusiasm about the collaboration, stating…
PR Newswire
20/08/2024
Altri  Comunicati